SXT Stock Analysis: Sensient Technologies | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 5.681m USD | 12M Return: 19.5% | US81725T1007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.7M
EPS Trend: 90.7%
Qual. Beats: 2
Rev. Trend: 98.6%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sensient Technologies Corporation (NYSE: SXT) is a U.S.-based specialty ingredients manufacturer headquartered in Milwaukee, Wisconsin, and incorporated in 1882. The company operates through three reportable segments-Flavors & Extracts, Color, and Asia Pacific-producing flavors, natural and synthetic colors, extracts, essential oils, dehydrated agricultural ingredients, and related specialty products for the food, beverage, personal care, pharmaceutical, nutraceutical, and industrial markets. Sensient sells its ingredients primarily on a business-to-business basis to consumer-goods manufacturers, with brands including Sensient Flavors, Sensient Food Colors, Sensient Pharmaceutical, Sensient Beauty, and Sensient Specialty Markets. The company is classified in the GICS Materials sector under Specialty Chemicals and trades as a mid-cap stock on the NYSE.
- FDA synthetic dye bans accelerate natural color demand
- Flavors and Extracts revenue tracks global food and beverage consumption
- Asia Pacific segment expansion drives emerging market growth
| Net Income: 158.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -2.67 > 1.0 |
| NWC/Revenue: 53.66% < 20% (prev 51.72%; Δ 1.93% < -1%) |
| CFO/TA 0.05 > 3% & CFO 123.4m > Net Income 158.0m |
| Net Debt (732.9m) to EBITDA (270.1m): 2.71 < 3 |
| Current Ratio: 4.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.7m) vs 12m ago 0.45% < -2% |
| Gross Margin: 34.65% > 18% (prev 33.28%; Δ 1.36% > 0.5%) |
| Asset Turnover: 74.46% > 50% (prev 71.47%; Δ 2.99% > 0%) |
| Interest Coverage Ratio: 7.74 > 6 (EBIT TTM 239.3m / Interest Expense TTM 30.9m) |
| A: 0.39 (Total Current Assets 1.18b - Total Current Liabilities 269.6m) / Total Assets 2.37b |
| B: 0.80 (Retained Earnings 1.91b / Total Assets 2.37b) |
| C: 0.10 (EBIT TTM 239.3m / Avg Total Assets 2.29b) |
| D: 1.13 (Book Value of Equity 1.26b / Total Liabilities 1.11b) |
| Altman-Z'' = 7.05 = AAA |
| DSRI: 1.04 (Receivables 376.5m/334.0m, Revenue 1.70b/1.58b) |
| GMI: 0.96 (GM 33.28% / 34.65%) |
| AQI: 0.91 (AQ_t 0.26 / AQ_t-1 0.28) |
| SGI: 1.08 (Revenue 1.70b / 1.58b) |
| TATA: 0.01 (NI 158.0m - CFO 123.4m) / TA 2.37b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of August 23, 2026, the stock is trading at USD 134.56 with a total of 340,922 shares traded. Over the past week, the price has changed by +0.82%, over one month by +23.91%, over three months by +19.38% and over the past year by +19.49%.
Current recommended Stop Loss: 125.30 (which is 6.9% or 2.3 ATR below the current price).
Sensient Technologies has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy SXT.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 142.8 | 6.1% |
P/E Trailing = 35.9757
P/E Forward = 22.7273
P/S = 3.3349
P/B = 4.5089
P/EG = 1.7352
Revenue TTM = 1.70b USD
EBIT TTM = 239.3m USD
EBITDA TTM = 270.1m USD
Long Term Debt = 763.5m USD (from longTermDebt, last quarter)
Short Term Debt = 397k USD (from shortTermDebt, last quarter)
Debt = 763.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 732.9m USD (calculated: Debt 763.9m - CCE 31.0m)
Enterprise Value = 6.41b USD (5.68b + Debt 763.9m - CCE 31.0m)
Interest Coverage Ratio = 7.74 (Ebit TTM 239.3m / Interest Expense TTM 30.9m)
EV/FCF = 1000.0x (Enterprise Value 6.41b / FCF TTM 4.48m)
FCF Yield = 0.07% (FCF TTM 4.48m / Enterprise Value 6.41b)
FCF Margin = 0.26% (FCF TTM 4.48m / Revenue TTM 1.70b)
Net Margin = 9.27% (Net Income TTM 158.0m / Revenue TTM 1.70b)
Gross Margin = 34.65% ((Revenue TTM 1.70b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 37.40% (prev 35.03%)
Tobins Q-Ratio = 2.70 (Enterprise Value 6.41b / Total Assets 2.37b)
Interest Expense / Debt = 4.05% (Interest Expense 30.9m / Debt 763.9m)
Taxrate = 24.20% (50.4m / 208.4m)
NOPAT = 181.4m (EBIT 239.3m * (1 - 24.20%))
Current Ratio = 4.39 (Total Current Assets 1.18b / Total Current Liabilities 269.6m)
Debt / Equity = 0.61 (Debt 763.9m / totalStockholderEquity, last quarter 1.26b)
Debt / EBITDA = 2.71 (Net Debt 732.9m / EBITDA 270.1m)
Debt / FCF = 163.5 (Net Debt 732.9m / FCF TTM 4.48m)
Total Stockholder Equity = 1.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.90% (Net Income 158.0m / Total Assets 2.37b)
RoE = 13.02% (Net Income TTM 158.0m / Total Stockholder Equity 1.21b)
RoCE = 12.11% (EBIT 239.3m / Capital Employed (Equity 1.21b + L.T.Debt 763.5m))
RoIC = 8.76% (NOPAT 181.4m / Invested Capital 2.07b)
WACC = 6.42% (E(5.68b)/V(6.44b) * Re(6.87%) + D(763.9m)/V(6.44b) * Rd(4.05%) * (1-Tc(0.24)))
Discount Rate = 6.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 97.27 | Cagr: 0.43%
[DCF] Terminal Value 73.10% ; FCFF base≈27.9m ; Y1≈24.5m ; Y5≈19.8m
[DCF] Fair Price = N/A (negative equity: EV 317.7m - Net Debt 732.9m = -415.2m; debt exceeds intrinsic value)
EPS Correlation: 90.68 | EPS CAGR: 11.60% | SUE: 2.48 | # QB: 2
Revenue Correlation: 98.60 | Revenue CAGR: 5.62% | SUE: 1.36 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.09 | Chg30d=+3.97% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=4.18 | Chg30d=+6.65% | Revisions=+50% | GrowthEPS=+20.2% | GrowthRev=+11.8%
EPS next Year (2027-12-31): EPS=4.96 | Chg30d=+5.44% | Revisions=+57% | GrowthEPS=+18.6% | GrowthRev=+13.2%
[Analyst] Revisions Ratio: +75% (up=9, down=0)